Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

In relapsed/refractory acute myeloid leukemia (AML), the prognostic impact of complete remission (CR) and measurable residual disease (MRD) negativity is not well established. We retrospectively analyzed 141 patients with relapsed/refractory AML who received first salvage therapy and had MRD assesse...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2020
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757010/
https://ncbi.nlm.nih.gov/pubmed/33351107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002811
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk